Open access · CC-BY
via OpenAlex
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
Davide Cangelosi, Martina Morini, Nicolò Zanardi, Angela Rita Sementa, Marco Muselli, Massimo Conte, Alberto Garaventa, Ulrich Pfeffer, Maria Carla Bosco, Luigi Varesio, Alessandra Eva
Cancers · 2020 · ▲ 66 citations
Abstract
The biological and clinical heterogeneity of neuroblastoma (NB) demands novel biomarkers and therapeutic targets in order to drive the most appropriate treatment for each patient. Hypoxia is a condition of low-oxygen tension occurring in poorly vascularized tumor tissues. In this study, we aimed to assess the role of hypoxia in the pathogenesis of NB and at developing a new clinically relevant hypoxia-based predictor of outcome. We analyzed the gene expression profiles of 1882 untreated NB primary tumors collected at diagnosis and belonging to four existing data sets. Analyses took advantage of machine learning methods. We identified NB-hop, a seven-gene hypoxia biomarker, as a predictor of NB patient prognosis, which is able to discriminate between two populations of patients with unfavorable or favorable outcome on a molecular basis. NB-hop retained its prognostic value in a multivariate model adjusted for established risk factors and was able to additionally stratify clinically relevant groups of patients. Tumors with an unfavorable NB-hop expression showed a significant association with telomerase activation and a hypoxic, immunosuppressive, poorly differentiated, and apoptosis-resistant tumor microenvironment. NB-hop defines a new population of NB patients with hypoxic tumors and unfavorable prognosis and it represents a critical factor for the stratification and treatment of NB patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cancers12092343
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Cangelosi, D., Morini, M., Zanardi, N., Sementa, A.R., Muselli, M., Conte, M., Garaventa, A., Pfeffer, U., Bosco, M.C., Varesio, L., & Eva, A. (2020). Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. <em>Cancers</em>. https://doi.org/10.3390/cancers12092343
Vancouver
Cangelosi D, Morini M, Zanardi N, Sementa AR, Muselli M, Conte M, et al. Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers. 2020. doi:10.3390/cancers12092343.
BibTeX
@article{davide2020Hypoxi,
title = {Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming},
author = {Davide Cangelosi and Martina Morini and Nicolò Zanardi and Angela Rita Sementa and Marco Muselli and Massimo Conte and Alberto Garaventa and Ulrich Pfeffer and Maria Carla Bosco and Luigi Varesio and Alessandra Eva},
journal = {Cancers},
year = {2020},
doi = {10.3390/cancers12092343},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Frontiers in Aging Neuroscience 2022
Open access · CC-BY
Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
Topics in medicinal chemistry 2019
Citation only
Sirtuin Inhibitors and Activators
Cancer 2002
Open access · OA
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma
Clinical Epigenetics 2020
Open access · CC-BY
Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 2025
Open access · US-GOV